VAPSE-based analysis: A two-phased candidate gene approach for elucidating genetic predisposition to complex disorders

Mutation Research - Mutation Research Genomics

Volumn 458, Issue 1-2, 2001, Pages 7-17

  Weinshenker, Brian G ^a   Sommer, Steve ^b  

^a MAYO CLINIC   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Multifactorial disease; SNP genetic epidemiology

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 9; DNA; DYSTROPHIN; GLUCOSE TRANSPORTER; GLYCOGEN SYNTHASE; HEXOKINASE; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; PHOSPHOTRANSFERASE; PRESENILIN 1; PRESENILIN 2; RNA;

ACCURACY; ALZHEIMER DISEASE; ANALYTIC METHOD; ARTICLE; ATAXIA TELANGIECTASIA; CYSTIC FIBROSIS; DNA SEQUENCE; DUCHENNE MUSCULAR DYSTROPHY; GENE IDENTIFICATION; GENE MAPPING; GENE MUTATION; GENETIC DISORDER; GENETIC EPIDEMIOLOGY; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; LINKAGE ANALYSIS; MISSENSE MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; THROMBOPHILIA;

ALZHEIMER DISEASE; DIABETES MELLITUS, TYPE 2; EPIDEMIOLOGIC METHODS; GENETIC DISEASES, INBORN; GENETIC HETEROGENEITY; GENETIC TECHNIQUES; GENOTYPE; HUMANS; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; PHENOTYPE; SEQUENCE ANALYSIS, DNA; STATISTICS; THROMBOPHILIA; VARIATION (GENETICS);

EID: 0035573902     PISSN: 13835726     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5726(00)00008-X     Document Type: Article

References (44)

1. Delineation of genetic predisposition to multifactorial disease: A general approach on the threshold of feasibility
2. Panning for gold: Genome-wide scanning for linkage in type I diabetes
3. The future of genetic studies of complex human diseases
4. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein
5. Mutation in blood coagulation factor V associated with resistance to activated protein C
6. Genetic factors in Alzheimer's disease: A review of recent advances
7. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
8. The genetic defect causing familial Alzheimer's disease maps on chromosome 21
9. The genetic defect in familial Alzheimer's disease is not tightly linked to the amyloid beta-protein gene
10. Molecular and prospective phenotypic characterization of a pedigree with familial Alzheimer's disease and a missense mutation in codon 717 of the beta-amyloid precursor protein gene
11. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jacob disease
12. Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease
13. Linkage studies in familial Alzheimer's disease: Evidence for chromosome 19 linkage
14. Candidate genes for insulin resistance
15. 3-adrenergic-receptor gene
16. A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus
17. Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus
18. Leu(UUR) gene
19. A new mitochondrial DNA mutation associated with non-insulin-dependent diabetes mellitus
20. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis
21. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis
22. Spectrum of CFTR mutations in cystic fibrosis and in congenital absence of the vas deferens in France
23. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia
24. Inactivation of ataxia-telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia
25. ATM mutations in B-cell chronic lymphocytic leukemia
26. Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia
27. The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy
28. Dystrophinopathy in isolated cases of myopathy in females
29. Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy
30. Association of nonsense mutation of dystrophin gene with disruption of sarcoglycan complex in X-linked dilated cardiomyopathy
31. Reported in vivo splice-site mutations in the factor IX gene: Severity of splicing defects and a hypothesis for predicting deleterious splice donor mutations
32. Missense mutations and evolutionary conservation of amino acids: Evidence that many of the amino acids in factor IX function as "spacer" elements
33. Two novel factor IX promoter mutations: Incremental progress towards "saturation in vivo mutagenesis" of a human promoter region
34. A novel method for detecting point mutations or polymorphisms and its application to population screening for carriers of phenylketonuria
35. PCR amplification of specific alleles (PASA) is a general method for rapidly detecting known single-base changes
36. Need to confirm promising case-control association studies: Reply to Sham
37. Genotype relative risks: Methods for design and analysis of candidate-gene association studies
38. Comparison of statistics for candidate-gene association studies with cases and parents
39. Novel association approach for determining the genetic predisposition to schizophrenia: Case-control resource and testing of a candidate-gene
40. Scanning of the dopamine D1 and D5 receptor genes by REF in neuropsychiatric patients reveals a novel missense change at a highly conserved amino acid
41. How much do we know about spontaneous human mutation rates?
42. Haplotype relative risks: An easy reliable way to construct a proper control sample for risk calculations
43. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM)